Profile data is unavailable for this security.
About the company
Ambu A/S is a Denmark-based company engaged in the development, manufacture and marketing of diagnostic and life-supporting devices for hospitals and rescue services. The Company’s operations are structured into three business areas: Anaesthesia, Patient Monitoring & Diagnostics and Emergency Care. The Anaesthesia business area offers a range of products such as resuscitators, face masks and laryngeal masks. The Patient Monitoring & Diagnostics business area comprises single use electrodes for cardiological and neurological examinations. The target groups for these products are hospitals, clinics, ambulance services and sleep labs. The Emergency Care business area offers ventilation bags, neck collars and manikins for first-aid training. The Company markets its products worldwide. The Company operates King Systems Inc, First Water Heathcote Ltd and Invendo Medical GmbH as subsidiaries.
- Revenue in DKK (TTM)6.09bn
- Net income in DKK544.00m
- Incorporated1956
- Employees5.43k
- LocationAmbu A/SBaltorpbakken 13BALLERUP 2750DenmarkDNK
- Phone+45 72252000
- Fax+45 72252050
- Websitehttps://www.ambu.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RaySearch Laboratories AB (publ) | 948.26m | 160.67m | 4.03bn | 458.00 | 27.89 | 6.45 | 11.01 | 4.25 | 6.65 | 6.65 | 39.25 | 28.74 | 0.6584 | 6.25 | 2.93 | 2,935,074.00 | 11.16 | 5.26 | 16.21 | 7.77 | 92.42 | 91.01 | 16.94 | 9.70 | 1.66 | 64.92 | 0.2861 | 52.38 | 12.77 | 15.58 | 11.93 | -- | 0.2213 | -- |
| Xvivo Perfusion AB | 572.91m | 17.75m | 4.11bn | 198.00 | 232.32 | 2.76 | 61.14 | 7.18 | 0.7968 | 0.7968 | 25.76 | 67.10 | 0.34 | 0.8939 | 6.13 | 4,101,844.00 | 1.05 | 3.28 | 1.12 | 3.52 | 73.81 | 73.86 | 3.10 | 10.87 | 3.68 | 1.83 | 0.0557 | 0.00 | -1.25 | 35.19 | -85.39 | -- | -- | -- |
| Arjo AB (publ) | 7.76bn | 235.61m | 4.84bn | 6.94k | 22.02 | 0.9862 | 4.81 | 0.6238 | 1.23 | 1.23 | 40.39 | 27.38 | 0.704 | 4.92 | 6.22 | 1,584,702.00 | 2.14 | 3.26 | 2.91 | 4.80 | 42.59 | 43.42 | 3.04 | 4.78 | 0.8494 | 4.19 | 0.4179 | 48.74 | -2.59 | 3.92 | -32.93 | -8.68 | -- | 2.25 |
| ChemoMetec A/S | 493.12m | 177.03m | 7.02bn | 172.00 | 39.66 | 10.76 | 34.35 | 14.24 | 10.17 | 10.17 | 28.33 | 37.50 | 0.6516 | 0.6662 | 5.54 | 2,679,973.00 | 23.39 | 27.48 | 27.93 | 34.02 | 83.83 | 80.53 | 35.90 | 36.41 | 3.06 | 95.21 | 0.0079 | 48.77 | 21.50 | 18.28 | 36.78 | 25.80 | 19.35 | 36.08 |
| Vitrolife AB | 2.43bn | -3.54bn | 8.57bn | 1.15k | -- | 1.54 | -- | 3.53 | -37.01 | -37.01 | 25.39 | 58.29 | 0.2407 | 3.44 | 5.24 | 2,987,837.00 | -35.09 | -9.46 | -36.79 | -9.86 | 58.24 | 57.81 | -145.74 | -49.19 | 2.73 | 11.33 | 0.169 | -- | -4.68 | 22.53 | -1,077.00 | -- | 68.15 | 6.58 |
| AddLife AB | 7.37bn | 395.03m | 11.48bn | 2.30k | 30.05 | 3.09 | 11.87 | 1.56 | 4.60 | 4.60 | 85.69 | 44.66 | 0.8105 | 3.83 | 5.87 | 4,549,891.00 | 4.36 | 3.82 | 6.05 | 5.80 | 38.09 | 37.80 | 5.38 | 4.66 | 0.6257 | 3.68 | 0.4671 | 31.71 | 1.52 | 14.64 | 122.22 | 1.58 | 22.47 | 0.00 |
| Embla Medical hf | 5.84bn | 524.49m | 13.18bn | 4.19k | 24.92 | 2.34 | 14.51 | 2.25 | 1.23 | 1.23 | 13.67 | 13.10 | 0.5681 | 2.27 | 6.96 | 1,394,276.00 | 5.12 | 4.60 | 6.10 | 5.43 | 62.30 | 62.25 | 9.01 | 7.99 | 0.9445 | 7.22 | 0.3768 | 0.00 | 8.63 | 8.09 | 22.05 | 68.07 | 6.12 | -- |
| Elekta AB (publ) | 12.39bn | 205.98m | 14.39bn | 4.48k | 72.39 | 2.50 | 12.93 | 1.16 | 0.7646 | 0.7646 | 45.97 | 22.11 | 0.5781 | 3.35 | 3.09 | 3,872,796.00 | 0.9511 | 3.48 | 1.70 | 6.21 | 38.17 | 38.22 | 1.65 | 6.02 | 0.7918 | 7.51 | 0.4724 | 92.20 | -0.5685 | 4.29 | -81.80 | -26.22 | 15.56 | 5.92 |
| Asker Healthcare Group AB | 11.84bn | 347.06m | 17.58bn | 4.58k | 49.01 | -- | 18.77 | 1.48 | 1.33 | 1.33 | 45.59 | -- | 1.12 | 5.14 | 8.48 | 3,665,284.00 | 3.41 | -- | 4.52 | -- | 40.92 | -- | 3.04 | -- | 0.8497 | 3.20 | 0.4688 | -- | 11.73 | -- | 36.67 | -- | -- | -- |
| Ambu A/S | 6.09bn | 544.00m | 19.36bn | 5.43k | 40.31 | 3.64 | 20.98 | 3.18 | 2.04 | 2.04 | 22.85 | 22.64 | 0.8135 | 1.95 | 7.18 | 1,130,201.00 | 7.27 | 4.06 | 8.49 | 4.82 | 60.07 | 59.33 | 8.94 | 5.48 | 1.67 | 20.74 | 0.0845 | 21.23 | 11.98 | 11.10 | 159.15 | 20.37 | -2.24 | 7.17 |
| Sectra AB | 1.58bn | 455.97m | 23.33bn | 1.32k | 54.12 | 19.56 | 43.47 | 14.78 | 3.36 | 3.36 | 11.62 | 9.29 | 0.6688 | -- | 3.93 | 1,726,353.00 | 19.32 | 15.75 | 35.74 | 29.92 | 54.43 | 60.29 | 28.89 | 22.41 | -- | -- | 0.0505 | 19.27 | 19.85 | 4.47 | 31.51 | 18.87 | 7.19 | -- |
| Getinge AB | 24.67bn | 1.59bn | 36.07bn | 11.79k | 24.27 | 1.86 | 11.73 | 1.46 | 8.29 | 8.29 | 128.39 | 108.05 | 0.5808 | 2.91 | 5.36 | -- | 3.78 | 4.48 | 4.94 | 5.91 | 47.63 | 47.54 | 6.51 | 7.57 | 0.8595 | 7.05 | 0.2696 | 47.51 | 0.6042 | 3.24 | 37.85 | -6.96 | 4.69 | 9.63 |
| Demant A/S | 22.97bn | 2.37bn | 37.67bn | 26.70k | 15.72 | 3.78 | -- | 1.64 | 11.21 | 7.31 | 108.71 | 46.67 | 0.6423 | 2.19 | 5.94 | 860,208.20 | 6.62 | 8.82 | 8.18 | 12.44 | 75.62 | 75.44 | 10.30 | 12.49 | 1.00 | 5.69 | 0.6791 | 0.00 | 2.46 | 9.69 | -18.09 | 16.13 | 5.16 | -- |
Data as of Feb 16 2026. Currency figures normalised to Ambu A/S's reporting currency: Danish Krone DKK
24.16%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Schroder Investment Management Ltd.as of 30 Nov 2025 | 13.40m | 5.70% |
| Capital Research & Management Co. (World Investors)as of 31 Dec 2025 | 8.06m | 3.43% |
| Nordea Investment Management AB (Denmark)as of 31 Dec 2025 | 6.61m | 2.82% |
| Brown Capital Management LLCas of 30 Sep 2025 | 5.35m | 2.28% |
| Fundsmith LLPas of 30 Jun 2025 | 5.32m | 2.26% |
| The Vanguard Group, Inc.as of 04 Feb 2026 | 5.27m | 2.24% |
| Artisan Partners LPas of 31 Dec 2025 | 3.50m | 1.49% |
| Norges Bank Investment Managementas of 30 Jun 2025 | 3.22m | 1.37% |
| Capital International Ltd.as of 31 Dec 2025 | 3.17m | 1.35% |
| BlackRock Fund Advisorsas of 06 Feb 2026 | 2.86m | 1.22% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
